Healthcare Press Micronesia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Press Micronesia.

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

Press releases published on January 12, 2026

January 12, 2026

Aclaris Therapeutics Initiates Phase 1b Proof-of-Concept Trial in Atopic Dermatitis (AD) with Its Novel Bispecific Antibody ATI-052

GlobeNewswire

January 12, 2026

ANI Pharmaceuticals Highlights Significant Growth in 2025, Provides 2026 Financial Guidance, and Outlines Strategic Priorities

GlobeNewswire

January 12, 2026

Pharvaris Outlines 2026 Strategic Priorities

GlobeNewswire

January 12, 2026

BioNTech präsentiert auf der 44. J.P. Morgan Healthcare-Konferenz Updates zur Geschäftsentwicklung und Schwerpunkte für das Jahr 2026

GlobeNewswire

January 12, 2026

BioNTech Provides Strategic Business Update and Outlines 2026 Areas of Focus at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire

January 12, 2026

Inspire Medical Systems, Inc. Announces Preliminary Unaudited Revenue Results for the Fourth Quarter and Full Year 2025 and Provides Initial 2026 Revenue Guidance

GlobeNewswire

January 12, 2026

Ocugen Announces Publication of Phase 1 GARDian1 Trial Results for OCU410ST Modifier Gene Therapy

GlobeNewswire

January 12, 2026

Biodesix Announces Preliminary Fourth Quarter and Full-Year 2025 Results (Unaudited)

GlobeNewswire

January 12, 2026

PathMaker Neurosystems Announces Completion of ALS Early-Feasibility Study of the MyoRegulator® Device for Non-Invasive Treatment of ALS

GlobeNewswire

January 12, 2026

Zymeworks Announces Leadership Appointments and Transitions to Align with Evolution of Corporate Strategy

GlobeNewswire

January 12, 2026

Teladoc Health Launches Enhanced 24/7 Care Service

GlobeNewswire

January 12, 2026

Cytek Biosciences Announces Preliminary Fourth Quarter and Full Year 2025 Revenue Results

GlobeNewswire

January 12, 2026

Communiqué de presse : Teizeild de Sanofi approuvé dans l'UE pour les patients atteints de diabète de type 1 de stade 2

GlobeNewswire

January 12, 2026

Press Release: Sanofi’s Teizeild approved in the EU for patients with stage 2 type 1 diabetes

GlobeNewswire

January 12, 2026

Publication relating to transparency notification

GlobeNewswire

January 12, 2026

argenx Highlights 2026 Strategic Priorities

GlobeNewswire

January 12, 2026

Publication relative à une notification de transparence

GlobeNewswire

January 12, 2026

Healthy Gut Announces Updated Holozyme Formula Addressing Digestive Sensitivity to Fructan-Containing Foods

GlobeNewswire

January 12, 2026

Expert Dermatologist Dr. Hannah Pederson, MD of Boulder/Niwot, Explains Why Skincare Routines Might Trigger Breakouts for HelloNation

GlobeNewswire

January 12, 2026

FDA Increases Flexibility on Requirements for Cell and Gene Therapies to Advance Innovation

GlobeNewswire